Screening, Assessment, and Treatment of Perinatal Mental Health in Obstetrical Settings.
Journal
Clinical obstetrics and gynecology
ISSN: 1532-5520
Titre abrégé: Clin Obstet Gynecol
Pays: United States
ID NLM: 0070014
Informations de publication
Date de publication:
01 Mar 2024
01 Mar 2024
Historique:
medline:
28
1
2024
pubmed:
28
1
2024
entrez:
28
1
2024
Statut:
ppublish
Résumé
Perinatal mood and anxiety disorders (PMADs) are common, yet obstetricians receive little training prior to independent practice on screening, assessing, diagnosing, and treating patients with depression and anxiety. Untreated PMADs lead to adverse pregnancy and fetal outcomes. Obstetricians are in a unique position to address PMADs. The following serves as a resource for addressing PMADs in obstetric practice.
Identifiants
pubmed: 38281173
doi: 10.1097/GRF.0000000000000840
pii: 00003081-202403000-00015
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
134-153Informations de copyright
Copyright © 2024 Wolters Kluwer Health, Inc. All rights reserved.
Références
Dennis CL, Falah-Hassani K, Shiri R. Prevalence of antenatal and postnatal anxiety: systematic review and meta-analysis. Br J Psychiatry. 2017;210:315–323.
Fawcett EJ, Fairbrother N, Cox ML, et al. The prevalence of anxiety disorders during pregnancy and the postpartum period: a multivariate Bayesian meta-analysis. J Clin Psychiatry. 2019;80.
Gaynes BN, Gavin N, Meltzer-Brody S, et al. Perinatal depression: prevalence, screening accuracy, and screening outcomes. Evid Rep Technol Assess (Summ). 2005;119:1–8.
Wisner KL, Sit DKY, McShea MC, et al. Onset timing, thoughts of self-harm, and diagnoses in postpartum women with screen-positive depression findings. JAMA Psychiatry. 2013;70:490.
Jarde A, Morais M, Kingston D, et al. Neonatal Outcomes in women with untreated antenatal depression compared with women without depression. JAMA Psychiatry. 2016;73:826.
McKee K, Admon LK, Winkelman TNA, et al. Perinatal mood and anxiety disorders, serious mental illness, and delivery-related health outcomes, United States, 2006-2015. BMC Womens Health. 2020;20:150.
Jahan N, Went TR, Sultan W, et al. Untreated depression during pregnancy and its effect on pregnancy outcomes: a systematic review. Cureus. 2021;13:e17251.
Simonovich SD, Nidey NL, Gavin AR, et al. Meta-analysis of antenatal depression and adverse birth outcomes in US populations, 2010-20. Health Aff (Millwood). 2021;40:1560–1565.
Gynecologists ACoOa Treatment and management of mental health conditions during pregnancy and postpartum. ACOG Clinical Practice Guideline No. 5. 2023. https://pubmed.ncbi.nlm.nih.gov/37486661/
Gynecologists ACoOa Screening and diagnosis of mental health conditions during pregnancy and postpartum. ACOG Clinical Practice Guideline No. 4. 2023. https://pubmed.ncbi.nlm.nih.gov/37486660/
Zlotnick C, Johnson SL, Miller IW, et al. Postpartum depression in women receiving public assistance: pilot study of an interpersonal-therapy-oriented group intervention. Am J Psychiatry. 2001;158:638–640.
Zlotnick C, Miller IW, Pearlstein T, et al. A preventive intervention for pregnant women on public assistance at risk for postpartum depression. Am J Psychiatry. 2006;163:1443–1445.
Zlotnick C, Tzilos G, Miller I, et al. Randomized controlled trial to prevent postpartum depression in mothers on public assistance. J Affect Disord. 2016;189:263–268.
Li H, Li H, Zhong J, et al. Association between sleep disorders during pregnancy and risk of postpartum depression: a systematic review and meta-analysis. Arch Womens Ment Health. 2023;26:259–267.
Fu T, Wang C, Yan J, et al. Relationship between antenatal sleep quality and depression in perinatal women: a comprehensive meta-analysis of observational studies. J Affect Disord. 2023;327:38–45.
Nakamura A, van der Waerden J, Melchior M, et al. Physical activity during pregnancy and postpartum depression: systematic review and meta-analysis. J Affect Disord. 2019;246:29–41.
Cohen LS, Altshuler LL, Harlow BL, et al. Relapse of major depression during pregnancy in women who maintain or discontinue antidepressant treatment. JAMA. 2006;295:499–507.
Miller ES, Grobman WA, Ciolino JD, et al. ACOG committee opinion no. 757: screening for perinatal depression. Obstet Gynecol. 2018;132:e208–e212.
Siu AL, Force USPST, Bibbins-Domingo K, et al. Screening for depression in adults: US Preventive Services Task Force recommendation statement. JAMA. 2016;315:380–387.
Avalos LA, Chen H, Li DK. Antidepressant medication use, depression, and the risk of preeclampsia. CNS Spectr. 2015;20:39–47.
Miller ES, Grobman WA, Ciolino JD, et al. Increased depression screening and treatment recommendations after implementation of a perinatal collaborative care program. Psychiatr Serv. 2021;72:1268–1275.
Cox JL, Holden JM, Sagovsky R. Detection of postnatal depression. Development of the 10-item Edinburgh Postnatal Depression Scale. Br J Psychiatry. 1987;150:782–786.
Wang L, Kroenke K, Stump TE, et al. Screening for perinatal depression with the Patient Health Questionnaire Depression Scale (PHQ-9): a systematic review and meta-analysis. Gen Hosp Psychiatry. 2021;68:74–82.
Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16:606–613.
McCabe-Beane JE, Segre LS, Perkhounkova Y, et al. The identification of severity ranges for the Edinburgh Postnatal Depression Scale. J Reprod Infant Psychol. 2016;34:293–303.
Mazzoni SE, Bott NL, Hoffman MC. Screening for perinatal anxiety. Am J Obstet Gynecol. 2021;224:628–629.
Sinesi A, Maxwell M, O’Carroll R, et al. Anxiety scales used in pregnancy: systematic review. BJPsych Open. 2019;5:e5.
Swalm D, Brooks J, Doherty D, et al. Using the Edinburgh Postnatal Depression Scale to screen for perinatal anxiety. Arch Womens Ment Health. 2010;13:515–522.
Kozhimannil KB, Interrante JD, Basile Ibrahim B, et al. Racial/ethnic disparities in postpartum health insurance coverage among rural and urban U.S. residents. J Womens Health (Larchmt). 2022;31:1397–1402.
Sidebottom A, Vacquier M, LaRusso E, et al. Perinatal depression screening practices in a large health system: identifying current state and assessing opportunities to provide more equitable care. Arch Womens Ment Health. 2021;24:133–144.
Hirschfeld RM, Williams JB, Spitzer RL, et al. Development and validation of a screening instrument for bipolar spectrum disorder: the Mood Disorder Questionnaire. Am J Psychiatry. 2000;157:1873–1875.
Frey BN, Simpson W, Wright L, et al. Sensitivity and specificity of the Mood Disorder Questionnaire as a screening tool for bipolar disorder during pregnancy and the postpartum period. J Clin Psychiatry. 2012;73:1456–1461.
Donald W, Black NCA. Introductory Textbook of Psychiatry, 6th edn. VA: American Psychiatric Publishing; 2014.
Bao C, Jin D, Sun S, et al. Trajectories and depressive symptoms during the perinatal period: a longitudinal population-based study in China. Front Psychiatry. 2022;13:762719.
Manber R, Bei B, Simpson N, et al. Cognitive behavioral therapy for prenatal insomnia: a randomized controlled trial. Obstet Gynecol. 2019;133:911–919.
Dinas PC, Koutedakis Y, Flouris AD. Effects of exercise and physical activity on depression. Ir J Med Sci. 2011;180:319–325.
Stubbs B, Vancampfort D, Rosenbaum S, et al. An examination of the anxiolytic effects of exercise for people with anxiety and stress-related disorders: a meta-analysis. Psychiatry Res. 2017;249:102–108.
Daley AJ, Foster L, Long G, et al. The effectiveness of exercise for the prevention and treatment of antenatal depression: systematic review with meta-analysis. BJOG. 2015;122:57–62.
McCurdy AP, Boule NG, Sivak A, et al. Effects of exercise on mild-to-moderate depressive symptoms in the postpartum period: a meta-analysis. Obstet Gynecol. 2017;129:1087–1097.
Perales M, Refoyo I, Coteron J, et al. Exercise during pregnancy attenuates prenatal depression: a randomized controlled trial. Eval Health Prof. 2015;38:59–72.
Madeline A, Becker MCH, Ballone NT, et al. Integrative approaches to perinatal depression. In: Hunter LAC LA, Nagle-Yang SM, Williams KE eds ,1st edn. Textbook of Women’s Reproductive Mental Health. DC: American Psychiatric Association Publishing; 2022;14:381–395.
Raghavan R, Dreibelbis C, Kingshipp BL, et al. Dietary patterns before and during pregnancy and birth outcomes: a systematic review. Am J Clin Nutr. 2019;109(suppl 7):729S–756S.
Silva DFO, Cobucci RN, Goncalves AK, et al. Systematic review of the association between dietary patterns and perinatal anxiety and depression. BMC Pregnancy Childbirth. 2019;19:212.
Sparling TM, Henschke N, Nesbitt RC, et al. The role of diet and nutritional supplementation in perinatal depression: a systematic review. Matern Child Nutr. 2017;13.
Deligiannidis KM, Freeman MP. Complementary and alternative medicine for the treatment of depressive disorders in women. Psychiatr Clin North Am. 2010;33:441–463.
Reza N, Deligiannidis KM, Eustis EH, et al. Complementary health practices for treating perinatal depression. Obstet Gynecol Clin North Am. 2018;45:441–454.
Epperson CN, Terman M, Terman JS, et al. Randomized clinical trial of bright light therapy for antepartum depression: preliminary findings. J Clin Psychiatry. 2004;65:421–425.
Wirz-Justice A, Bader A, Frisch U, et al. A randomized, double-blind, placebo-controlled study of light therapy for antepartum depression. J Clin Psychiatry. 2011;72:986–993.
Dimidjian S, Goodman SH, Felder JN, et al. Staying well during pregnancy and the postpartum: a pilot randomized trial of mindfulness-based cognitive therapy for the prevention of depressive relapse/recurrence. J Consult Clin Psychol. 2016;84:134–145.
Shi Z, MacBeth A. The effectiveness of mindfulness-based interventions on maternal perinatal mental health outcomes: a systematic review. Mindfulness (N Y). 2017;8:823–847.
Li C, Sun X, Li Q, et al. Role of psychotherapy on antenatal depression, anxiety, and maternal quality of life: a meta-analysis. Medicine (Baltimore). 2020;99:e20947.
Field T, Diego M, Delgado J, et al. Peer support and interpersonal psychotherapy groups experienced decreased prenatal depression, anxiety, and cortisol. Early Hum Dev. 2013;89:621–624.
Felder JN, Segal Z, Beck A, et al. An open trial of web-based mindfulness-based cognitive therapy for perinatal women at risk for depressive relapse. Cogn Behav Pract. 2017;24:26–37.
Forsell E, Bendix M, Hollandare F, et al. Internet-delivered cognitive behavior therapy for antenatal depression: a randomised controlled trial. J Affect Disord. 2017;221:56–64.
Kelman AR, Evare BS, Barrera AZ, et al. A proof-of-concept pilot randomized comparative trial of brief Internet-based compassionate mind training and cognitive-behavioral therapy for perinatal and intending to become pregnant women. Clin Psychol Psychother. 2018. https://pubmed.ncbi.nlm.nih.gov/29473698/.
Loughnan SA, Sie A, Hobbs MJ, et al. A randomized controlled trial of “MUMentum Pregnancy”: internet-delivered cognitive behavioral therapy program for antenatal anxiety and depression. J Affect Disord. 2019;243:381–390.
Battle CL, Salisbury AL, Schofield CA, et al. Perinatal antidepressant use: understanding women’s preferences and concerns. J Psychiatr Pract. 2013;19:443–453.
Goodman JH. Women’s attitudes, preferences, and perceived barriers to treatment for perinatal depression. Birth. 2009;36:60–69.
Sit DK, Perel JM, Helsel JC, et al. Changes in antidepressant metabolism and dosing across pregnancy and early postpartum. J Clin Psychiatry. 2008;69:652–658.
Gartlehner G, Hansen RA, Morgan LC, et al. In: Second-Generation Antidepressants in the Pharmacologic Treatment of Adult Depression: An Update of the 2007 Comparative Effectiveness Review. 2011. https://www.ncbi.nlm.nih.gov/books/NBK570101/
Nemeroff CB, DeVane CL, Pollock BG. Newer antidepressants and the cytochrome P450 system. Am J Psychiatry. 1996;153:311–320.
Huybrechts KF, Bateman BT, Palmsten K, et al. Antidepressant use late in pregnancy and risk of persistent pulmonary hypertension of the newborn. JAMA. 2015;313:2142–2151.
Yang A, Ciolino JD, Pinheiro E, et al. Neonatal discontinuation syndrome in serotonergic antidepressant-exposed neonates. J Clin Psychiatry. 2017;78:605–611.
Kieviet N, Hoppenbrouwers C, Dolman KM, et al. Risk factors for poor neonatal adaptation after exposure to antidepressants in utero. Acta Paediatr. 2015;104:384–391.
Trinh NTH, Munk-Olsen T, Wray NR, et al. Timing of antidepressant discontinuation during pregnancy and postpartum psychiatric outcomes in Denmark and Norway. JAMA Psychiatry. 2023;80:441–450.
Warburton W, Hertzman C, Oberlander TF. A register study of the impact of stopping third-trimester selective serotonin reuptake inhibitor exposure on neonatal health. Acta Psychiatr Scand. 2010;121:471–479.
Hutner LA, Catapano LA, Nagle-Yang SM, et al. Textbook of women’s reproductive mental health. American Psychiatric Association Publishing; 2021.
Baldwin DS, Foong T. Antidepressant drugs and sexual dysfunction. Br J Psychiatry. 2013;202:396–397.
Thase ME. The small specific effects of antidepressants in clinical trials: what do they mean to psychiatrists? Curr Psychiatry Rep. 2011;13:476–482.
Lowe B, Unutzer J, Callahan CM, et al. Monitoring depression treatment outcomes with the patient health questionnaire-9. Med Care. 2004;42:1194–1201.
Simon G. Choosing a first-line antidepressant. JAMA. 2001;286:3003.
Thase ME, Blomgren SL, Birkett MA, et al. Fluoxetine treatment of patients with major depressive disorder who failed initial treatment with sertraline. J Clin Psychiatry. 1997;58:16–21.
Zarate CA, Kando JC, Tohen M, et al. Does intolerance or lack of response with fluoxetine predict the same will happen with sertraline? J Clin Psychiatry. 1996;57:67–71.
Brown WA, Harrison W. Are patients who are intolerant to one serotonin selective reuptake inhibitor intolerant to another? J Clin Psychiatry. 1995;56:30–34.
Dolovich LR, Addis A, Vaillancourt JM, et al. Benzodiazepine use in pregnancy and major malformations or oral cleft: meta-analysis of cohort and case-control studies. BMJ. 1998;317:839–843.
Wikner BN, Stiller CO, Bergman U, et al. Use of benzodiazepines and benzodiazepine receptor agonists during pregnancy: neonatal outcome and congenital malformations. Pharmacoepidemiol Drug Saf. 2007;16:1203–1210.
Viswanathan M, Middleton JC, Stuebe A, et al. 1st edn In: Maternal, Fetal, and Child Outcomes of Mental Health Treatments in Women: a Systematic Review of Perinatal Pharmacologic Interventions. 2021. https://www.ncbi.nlm.nih.gov/books/NBK83442/
Deligiannidis KM, Meltzer-Brody S, Maximos B, et al. Zuranolone for the treatment of postpartum depression. Am J Psychiatry. 2023;180:668–675.
Postpartum Support International Directory Postpartum Support International. Accessed September 19, 2023. https://psidirectory.com/
Byatt N, Biebel K, Moore Simas TA, et al. Improving perinatal depression care: the Massachusetts Child Psychiatry Access Project for Moms. Gen Hosp Psychiatry. 2016;40:12–17.
Byatt N, Pbert L, Hosein S, et al. PRogram In Support of Moms (PRISM): development and beta testing. Psychiatr Serv. 2016;67:824–826.
Byatt N, Moore Simas TA, Biebel K, et al. PRogram In Support of Moms (PRISM): a pilot group randomized controlled trial of two approaches to improving depression among perinatal women. J Psychosom Obstet Gynaecol. 2018;39:297–306.
Hutner LA, Yeaton-Massey A, Toscano M, et al. Cultivating mental health education in obstetrics and gynecology: a call to action. Am J Obstet Gynecol MFM. 2021;3:100459.
Postpartum Support International Certification in perinatal mental health. Accessed September 19, 2023. https://www.postpartum.net/professionals/certification/?gclid=CjwKCAjwue6hBhBVEiwA9YTx8IUII5BFQSZ9ysrqv3bcZAS1iDiR7B6SzpMCmUSszqa6TvtyvVQtPBoCkbcQAvD_BwE#toggle-id-2
Massachusetts General Hospital Psychiatry Academy Courses-Women’s Mental Health. Accessed September 19, 2023. https://lms.mghcme.org/course-catalog-list?f%5B0%5D=field_course_category%3A144